Search research articles
Contact Us
Filters
Showing results (91-100 of 112) with videos related to
Page
of 12
Sort By:
Disease Models & Mechanisms
|
September 22, 2025
FAK modulates glioblastoma stem cell energetics via regulation of glycolysis and glutamine oxidation
Roza H A Masalmeh, John C Dawson, Virginia Alvarez Garcia, et al.
Developmental Cell
|
September 26, 2024
An ILK/STAT3 pathway controls glioblastoma stem cell plasticity
Alexander E P Loftus, Marianna S Romano, Anh Nguyen Phuong, et al.
Cell Systems
|
May 3, 2016
Bistability in the Rac1, PAK, and RhoA Signaling Network Drives Actin Cytoskeleton Dynamics and Cell Motility Switches
Kate M Byrne, Naser Monsefi, John C Dawson, et al.
Iscience
|
May 28, 2026
A comprehensive pharmacological survey across heterogeneous patient-derived glioblastoma stem cell models
Richard J R Elliott, Peter W K Nagle, Muhammad Furqan, et al.
Cancer Biology & Therapy
|
November 30, 2025
High-throughput screening identifies the activity of histone deacetylase inhibitors in patient-derived models of soft tissue sarcoma
Molly R Danks, Piotr J Manasterski, Henry Beetham, et al.
Cell Death & Disease
|
November 8, 2023
Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells
Yakinthi Chrisochoidou, Rajat Roy, Pooyeh Farahmand, et al.
Scientific Reports
|
April 5, 2018
Blocking distinct interactions between Glioblastoma cells and their tissue microenvironment: A novel multi-targeted therapeutic approach
Melanie Mettang, Viola Meyer-Pannwitt, Georg Karpel-Massler, et al.
Cancer Research
|
June 11, 2013
Intravital FLIM-FRET imaging reveals dasatinib-induced spatial control of src in pancreatic cancer
Max Nobis, Ewan J McGhee, Jennifer P Morton, et al.
Gynecologic Oncology
|
April 6, 2024
High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinoma
Robert L Hollis, Richard Elliott, John C Dawson, et al.
Cell Chemical Biology
|
October 9, 2018
ALDH1 Bio-activates Nifuroxazide to Eradicate ALDH<sup>High</sup> Melanoma-Initiating Cells
Sana Sarvi, Richard Crispin, Yuting Lu, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 112) with videos related to
Sort By:
Page
of 12
Disease Models & Mechanisms
|
September 22, 2025
FAK modulates glioblastoma stem cell energetics via regulation of glycolysis and glutamine oxidation
Roza H A Masalmeh, John C Dawson, Virginia Alvarez Garcia, et al.
Developmental Cell
|
September 26, 2024
An ILK/STAT3 pathway controls glioblastoma stem cell plasticity
Alexander E P Loftus, Marianna S Romano, Anh Nguyen Phuong, et al.
Cell Systems
|
May 3, 2016
Bistability in the Rac1, PAK, and RhoA Signaling Network Drives Actin Cytoskeleton Dynamics and Cell Motility Switches
Kate M Byrne, Naser Monsefi, John C Dawson, et al.
Iscience
|
May 28, 2026
A comprehensive pharmacological survey across heterogeneous patient-derived glioblastoma stem cell models
Richard J R Elliott, Peter W K Nagle, Muhammad Furqan, et al.
Cancer Biology & Therapy
|
November 30, 2025
High-throughput screening identifies the activity of histone deacetylase inhibitors in patient-derived models of soft tissue sarcoma
Molly R Danks, Piotr J Manasterski, Henry Beetham, et al.
Cell Death & Disease
|
November 8, 2023
Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells
Yakinthi Chrisochoidou, Rajat Roy, Pooyeh Farahmand, et al.
Scientific Reports
|
April 5, 2018
Blocking distinct interactions between Glioblastoma cells and their tissue microenvironment: A novel multi-targeted therapeutic approach
Melanie Mettang, Viola Meyer-Pannwitt, Georg Karpel-Massler, et al.
Cancer Research
|
June 11, 2013
Intravital FLIM-FRET imaging reveals dasatinib-induced spatial control of src in pancreatic cancer
Max Nobis, Ewan J McGhee, Jennifer P Morton, et al.
Gynecologic Oncology
|
April 6, 2024
High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinoma
Robert L Hollis, Richard Elliott, John C Dawson, et al.
Cell Chemical Biology
|
October 9, 2018
ALDH1 Bio-activates Nifuroxazide to Eradicate ALDH<sup>High</sup> Melanoma-Initiating Cells
Sana Sarvi, Richard Crispin, Yuting Lu, et al.
Page
of 12